Imaging technology company Adaptix has begun live imaging trials as part of a research programme at the University of Exeter. Patients suspected of having rheumatoid arthritis will be the first in the country to use its Adaptix Ortho350 digital tomosynthesis technology to help diagnose and track the progression of the disease in their hands. The […]
Read MoreAdaptix has received 510(k) clearance from the USA FDA for its 3D imaging product, the Adaptix Ortho350. The mobile, low dose digital tomosynthesis orthopaedic system is designed to deliver fast, lower cost 3D x-rays at the point of care. It was developed specifically to image upper and lower extremities at a fraction of the radiation […]
Read MoreIt has been a busy 12 months for UK-based imaging technology company Adaptix, with the official launch of its orthopaedic 3D imaging system, the Adaptix Ortho350, in the UK. CEO Sarah Small said: “It has been a fast-paced but rewarding 12 months since we were last at RSNA. The UK launch of our Adaptix Ortho350 […]
Read MoreAdaptix will be officially launching its latest 3D imaging system, the Adaptix Ortho350. As part of the official product launch, Adaptix will have a range of exclusive offers available on it stand, where visitors will also be able to see the technology up close as the company delivers live x-ray imaging throughout the conference. The […]
Read More
